Increased INR after gefitinib and acenocoumarol co-administration.

Ribed, A; Escudero-Vilaplana, V; Gonzalez-Haba, E; Sanjurjo, M

Ribed, A; Escudero-Vilaplana, V; Gonzalez-Haba, E; Sanjurjo, M.

Affiliation

Ribed A; Pharmacy Department, Gregorio Marañón University Hospital, Madrid, Spain. almudena.ribed@salud.madrid.org.

Eur Rev Med Pharmacol Sci ; 18(12): 1720-2, 2014.

Article in En | MEDLINE | ID: mdl-24992614

Subject(s)

Acenocoumarol/adverse effects; Anticoagulants/adverse effects; Antineoplastic Agents/adverse effects; Protein Kinase Inhibitors/adverse effects; Quinazolines/adverse effects; Adenocarcinoma/drug therapy; Aged; Atrial Fibrillation/drug therapy; Carcinoma, Non-Small-Cell Lung/drug therapy; Drug Interactions; Gefitinib; Heart Failure/drug therapy; Humans; International Normalized Ratio; Lung Neoplasms/drug therapy; Male

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Protein Kinase Inhibitors / Acenocoumarol / Anticoagulants / Antineoplastic Agents Limits: Aged / Humans / Male Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2014 Document type: Article Affiliation country: Spain

Search on Google

Add to My VHL

XML

PubMed Links